文献速递妇科

诊室子宫托护理时间安排:一项随机对照试验

Timing of Office-Based Pessary Care: A Randomized Controlled Trial.
PubMed 文献 · Obstet Gynecol · 2020-01-01

本研究为随机、非劣效性试验,纳入使用环型、Gellhorn或失禁碟型子宫托的成年女性,1:1随机分为每12周随访的常规组和每24周随访的延长组,主要结局为48周时阴道上皮异常(上皮破损或糜烂)发生率,非劣效界值为7.5%。结果显示常规组发生率为7.4%,延长组为1.7%(差值-5.7个百分点,95%CI -7.4至-4),达到非劣效标准;延长子宫托使用时间(P=.003)和既往上皮异常史(P=.01)与上皮异常发生相关。

要点

  • 每24周随访的延长组阴道上皮异常发生率1.7%,每12周常规组为7.4%,达到非劣效。
  • 延长子宫托使用时间(P=.003)和既往上皮异常史(P=.01)与上皮异常发生相关。
  • 除上皮异常外,两组均未发生与子宫托使用相关的其他不良事件。

核心结论

  • 在使用环型、Gellhorn或失禁碟型子宫托并接受诊室子宫托护理的女性中,基于阴道上皮异常发生率,每24周常规随访非劣效于每12周随访。

研究设计与样本

  • 随机、非劣效性试验,2015年1月至2017年6月筛查448例,随机130例,常规组64例、延长组66例。

主要发现

  • 48周时阴道上皮异常发生率常规组7.4% vs 延长组1.7%(差值-5.7个百分点,95%CI -7.4至-4),达到非劣效标准。
  • 两组在任何时间点各类型上皮异常发生率均无差异。
  • 延长子宫托使用时间(P=.003)和既往上皮异常史(P=.01)与上皮异常发生相关。
  • 除上皮异常外,两组均未发生与子宫托使用相关的其他不良事件。

关键数值与推荐

  • 预设非劣效界值为7.5%。
  • 主要结局为48周最终研究访视时阴道上皮异常(上皮破损或糜烂)发生率。
  • 常规组每12周诊室随访,延长组每24周诊室随访。

临床怎么用

  • 对于使用环型、Gellhorn或失禁碟型子宫托并接受诊室护理的女性,可考虑每24周随访一次。
  • 延长子宫托使用时间和既往上皮异常史与上皮异常发生相关,需关注。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the influence of pessary visit intervals on development of vaginal epithelial abnormalities. METHODS: We conducted a randomized, noninferiority trial of office-based pessary care. Eligible participants were adult women wearing a ring, Gellhorn, or incontinence dish pessary to treat pelvic organ prolapse or incontinence or both. Patients were randomized 1:1 to routine pessary care (office visits every 12 weeks, "routine" arm) or to extended pessary care (office visits every 24 weeks, "extended" arm). The primary study outcome was rate of vaginal epithelial abnormalities (epithelial break or erosion) at the final study visit (48 weeks). The predetermined noninferiority margin was 7.5%. RESULTS: From January 2015 through June 2017, inclusive, 448 patients were screened and 130 were randomized, 64 to the routine arm and 66 to the extended arm. Baseline characteristics of the study arms were similar with the exception of pessary type, with ring pessary more common in the routine arm and Gellhorn pessary more common in the extended arm (P=.02). The rate of epithelial abnormalities at the final study visit (48 weeks) was 7.4% in the routine arm and 1.7% in the extended arm (difference, -5.7 percentage points; 95% CI -7.4 to -4), which met the criterion for noninferiority. Rates of all types of epithelial abnormalities did not differ between arms at any time point. Increasing duration of pessary use (P=.003) and history of prior epithelial abnormalities were associated with development of epithelial abnormalities (P=.01). Other than epithelial abnormalities, no adverse events related to pessary use occurred in either arm. CONCLUSION: In women who receive office-based pessary care and are using a ring, Gellhorn, or incontinence dish pessary, routine follow-up every 24 weeks is noninferior to every 12 weeks based on incidence of vaginal epithelial abnormalities. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT02371083.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Propst K, Mellen C, O'Sullivan DM, et al. Timing of Office-Based Pessary Care: A Randomized Controlled Trial. Obstet Gynecol. 2020. PMID: 31809432. doi:10.1097/AOG.0000000000003580

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。